Four new Commissioners will join the Commission on Human
Medicines (CHM) on 1 May 2021.
Professor Amanda Adler, Professor Sandosh Padmanabhan, Professor
Steve Cunningham and Professor Yvonne Perrie have been appointed
as Commissioners of the CHM for four years, in accordance with
the Cabinet Office Code of Governance for Public Appointments.
The CHM provides independent expert advice to ministers on the
safety, quality and efficacy of medicines, and on adverse
reactions including those reported under the Yellow Card Scheme.
It is an advisory non-departmental public body, sponsored by the
Department of Health and Social Care.
Sandosh Padmanabhan, Professor of Cardiovascular Genomics
and Therapeutics at the University of Glasgow and the University
of Toledo, said:
“I am delighted to be appointed as a Commissioner of the CHM. I
look forward to working with the Commission on its independent
and scientific assessments related to licensing new medicines and
monitoring their safety. I hope to contribute to the broad remit
of the CHM, along with my expertise in precision medicine,
pharmacogenomics and cardiovascular medicine.”
Professor Steve Cunningham, Consultant in Paediatric
Respiratory Medicine at the Children’s hospital in Edinburgh,
said:
“I am delighted to be appointed to the CHM as the principal
representative of paediatric medicines. There are novel
opportunities to enhance the safe, efficient and effective
delivery of medicines for children and young people within the
UK. I look forward to helping shape the environment that will
encourage this.”
Yvonne Perrie, Professor in Drug Delivery at Strathclyde
Institute of Pharmacy and Biomedical Sciences, said:
“I am delighted to be appointed to the internationally respected
CHM as a Commissioner. I am looking forward to providing my
pharmaceutical knowledge to support the CHM in their role in
advising ministers on the safety, efficacy and quality of
medicinal products.”
Notes to Editor
- The appointments will involve a time commitment of
approximately 22 days per year, including 11 meetings and any
ad-hoc meetings based on need. Remuneration for the roles will be
at a rate of £325 per meeting
· These appointments are made in accordance with the Cabinet
Office Code of Governance for Public Appointments. The regulation
of public appointments against the requirements of this Code is
carried out by the Commissioner for Public Appointments.
- The appointments are made on merit and political activity
played no part in the decision process. However, in accordance
with the Code, there is a requirement for appointees’ political
activity (if any declared) to be made public. None have declared
any political activity.
-
Professor Amanda Adler is Professor of
Diabetic Medicine and Health Policy at Oxford University, and
Director of the Diabetes Trials Unit within the Oxford Centre
for Diabetes, Endocrinology and Metabolism. Trained in
economics, medicine, and epidemiology in the US, and
pharmacoepidemiology and pharmacovigilance in the UK. She has
advised the UK National Screening Committee and the World
Health Organization (WHO) as a technical expert.
-
Professor Steve Cunningham is a Consultant in
Paediatric Respiratory Medicine at the Children’s hospital in
Edinburgh, having worked at Great Ormond Street and Australia’s
Sydney Children’s Hospital. He is currently Vice Chair of the
MHRA’s Paediatric Medicines Expert Advisory Group and Chair of
the European Respiratory Society Clinical Research
Collaboration. Steve was Chair of the NICE Bronchiolitis
guideline and Chief Investigator of Bronchiolitis of Infancy
Discharge study.
-
Professor Sandosh Padmanabhan is a professor
of Cardiovascular Genomics and Therapeutics at the University
of Glasgow and the University of Toledo, Ohio, USA, and an
Honorary Consultant Physician at the Western Infirmary in
Glasgow. He has led on a genome wide association analysis of
hypertension. He was a visiting fellow to the Broad Institute
of Harvard and Massachusetts Institute of Technology. He is a
Fellow of the Royal College of Physicians, the British
Hypertension Society and the American Heart Association, and
examiner for the Royal Colleges of Medicine.
-
Professor Yvonne Perrie is a professor in Drug
Delivery at Strathclyde Institute of Pharmacy and Biomedical
Sciences, a role she also held at Aston University. She is also
Associate Dean (Research) within the Faculty of Science. Her
previous roles include Associate Dean for Learning and
Teaching, Director of the Medicines Research Unit and Head of
Pharmacy. Professor Perrie has also worked within the newly
established drug delivery company, Lipoxen Technologies Ltd,
developing their liposome drug delivery platform technology.
· More
information on the Commission for Human Medicines.
